U.S. markets close in 4 hours 53 minutes
  • S&P 500

    4,587.62
    -67.65 (-1.45%)
     
  • Dow 30

    34,601.04
    -534.90 (-1.52%)
     
  • Nasdaq

    15,552.33
    -230.50 (-1.46%)
     
  • Russell 2000

    2,213.51
    -28.47 (-1.27%)
     
  • Crude Oil

    67.01
    -2.94 (-4.20%)
     
  • Gold

    1,788.10
    +2.90 (+0.16%)
     
  • Silver

    22.95
    +0.10 (+0.45%)
     
  • EUR/USD

    1.1266
    -0.0027 (-0.24%)
     
  • 10-Yr Bond

    1.4700
    -0.0600 (-3.92%)
     
  • GBP/USD

    1.3223
    -0.0089 (-0.67%)
     
  • USD/JPY

    113.5600
    -0.0480 (-0.04%)
     
  • BTC-USD

    57,348.89
    +220.22 (+0.39%)
     
  • CMC Crypto 200

    1,463.74
    +20.97 (+1.45%)
     
  • FTSE 100

    7,085.08
    -24.87 (-0.35%)
     
  • Nikkei 225

    27,821.76
    -462.16 (-1.63%)
     

Is Ocugen Stock Heading for a Crash?

·4 min read
Is Ocugen Stock Heading for a Crash?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Ocugen (NASDAQ: OCGN) shares took center stage earlier this year when the biotech joined the coronavirus vaccine race. The company partnered with India's Bharat Biotech to co-develop and co-commercialize Bharat's vaccine candidate -- Covaxin -- in the U.S. As a result, Ocugen shares soared as much as 763% in about six weeks. Now, some investors might be wondering if Ocugen will hang onto this positive momentum -- or whether the stock is heading for a crash.